Esperion Therapeutics | Brutto Fortjeneste På Salg

Gross Profit On Sales Endring Dato
AbbVie USD 9.56B 95M 2023-09
Alnylam Pharmaceuticals USD 353.86M 312.36M 2023-12
Amarin USD 42.5M 14.47M 2023-09
Amgen USD 5.08B 14M 2023-12
Cipla INR 43.65B 2.73B 2023-09
CSL USD 2.98B 882.4M 2023-06
Daiichi Sankyo JPY 280.77B 23.61B 2023-09
Eli Lilly USD 7.57B 73.1M 2023-12
Grifols EUR 631.83M 13.37M 2023-09
Halozyme Therapeutics USD 177.74M 16.53M 2023-12
Intra Cellular Therapies USD 121.4M 4.35M 2023-12
Ionis Pharmaceuticals USD 321.44M 179.43M 2023-12
Merck USD 11.29B 441M 2023-12
Moderna USD 1.88B 2.29B 2023-12
Pfizer USD 7.58B 3.26B 2023-12
PTC Therapeutics USD 277.94M 90.85M 2023-12
Regeneron Pharmaceuticals USD 2.92B 9M 2023-12
Sarepta Therapeutics USD 294.79M 67.68M 2023-09
United Therapeutics USD 543.7M 4.4M 2023-12



Esperion Therapeutics Brutto Fortjeneste På Salg - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2024.